Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Techniques for cytologic sampling of pancreatic and bile duct lesions
Brugge, William R. , Klapman, Jason, Ashfaq, Raheela, Shidham, Vinod B. , Chhieng, David C., Kwon, Richard S. , Zarka, Matthew A., Staerkel, Gregg, DeWitt, John M. , Baloch, Zubair

Diagnostic Cytopathology | February 19, 2014 | Volume: 42 | Issue: 4 | Pages: 333-337

10.1002/dc.23096 | PMID 24554498 Get It

The Papanicolaou Society of Cytopathology has developed a set of guidelines for pancreatobiliary cytology including indications for endoscopic ultrasound guided fine‐needle aspiration biopsy, techniques of the endoscopic retrograde cholangiopancreatography, terminology and nomenclature of pancreatobiliary disease, ancillary testing, and postbiopsy management. All documents are based on the expertise of the authors, a review of the literature, discussions of the draft document at several national and international meetings over an 18‐month period and synthesis of online comments of the draft document on the Papanicolaou Society of Cytopathology website [www.papsociety.org]. This document presents the results of these discussions regarding the use of ancillary testing in the cytological diagnosis of biliary and pancreatic lesions. This document summarizes the current state of the art for techniques in acquiring cytology specimens from the biliary tree as well as solid and cystic lesions of the pancreas. Diagn. Cytopathol. 2014;42:333–337. © 2014 Wiley Periodicals, Inc.
Delayed surgical debridement in pediatric open fractures: A systematic review and meta-analysis
Ibrahim, Talal , Riaz, Muhammad , Hegazy, Abdelsalam , Erwin, Patricia J., Tleyjeh, Imad M. , Tleyjeh, Imad M

Journal of Children's Orthopaedics | February 19, 2014 | Volume: 8 | Issue: 2 | Pages: 135-141

10.1007/s11832-014-0567-2 | PMID 24554129 Get It

Purpose Open fractures are considered orthopedic emergencies that are traditionally treated with surgical debridement within 6 h of injury to prevent infection. However, this proclaimed “6-h rule” is arbitrary and not based on rigorous scientific evidence. The aim of our study was to systematically review the literature that compares late (>6 h from the time of injury) to early (<6 h from the time of injury) surgical debridement of pediatric open fractures. Methods We searched several databases from 1946 to 2013 for any observational or experimental studies that evaluated late and early surgical debridement of pediatric open fractures. We performed a meta-analysis using a random effects model to pool odds ratios for a comparison of infection rates between children undergoing late versus early surgical debridement. We also investigated the infection rates in upper- and lower-limb pediatric open fractures. Descriptive, quantitative, and qualitative data were extracted. Results Of the 12 articles identified, three studies (retrospective cohort studies) were eligible for the meta-analysis, encompassing a total of 714 open fractures. The pooled odds ratio (OR = 0.79) for infection between late and early surgical debridement was in favor of late surgical debridement but was not statistically significant (95 % CI 0.32, 1.99; p = 0.38, I 2 = 0 %). No significant difference in infection rate was detected between pediatric open fractures in the upper and lower limbs according to the time threshold in the included studies (OR = 0.72, 95 % CI 0.29, 1.82; p = 0.40, I 2 = 0 %). Conclusions The cumulative evidence does not, at present, indicate an association between late surgical debridement and higher infection rates in pediatric open fractures. However, initial expedient surgical debridement of open fractures in children should always remain the rule. Thus, multi-center randomized controlled trials or prospective cohort studies will be able to answer this question with more certainty and a higher level of evidence. Level of evidence Level III.
Pain-free Surgery or Pain-free Parking: Measuring Patient Satisfaction with Perioperative Care Is Humbling for the Anesthesiologist
Hyder, Joseph A.

Anesthesiology | February 19, 2014 | Volume: 120 | Issue: 3 | Pages: 780-781

10.1097/aln.0000000000000110 | PMID 24534860 Get It

Retinal Microvascular Abnormalities Predict Progression of Brain Microvascular Disease
Hanff, Thomas C. , Sharrett, A. Richey, Shibata, Dean , Mosley, Thomas H. , Knopman, David S. , Klein, Ronald , Gottesman, Rebecca F.

Stroke | February 19, 2014 | Volume: 45 | Issue: 4 | Pages: 1012-1017

10.1161/strokeaha.113.004166 | PMID 24549866 Get It

Background and Purpose— Brain microvascular disease leads to leukoaraiosis and lacunar infarcts and contributes to risk of stroke and cognitive decline. Given a shared pathophysiology, retinal microvascular signs are expected to predict brain microvascular disease progression. We investigated if either leukoaraiosis volume progression measured continuously or combined with incident lacunar infarcts would better demonstrate expected associations with retinal disease than has previously been shown. Methods— Eight hundred thirty participants in the Atherosclerosis Risk in Communities (ARIC) study aged ≥55 years and without previous stroke received an initial brain magnetic resonance imaging, retinal photography, and, 10 years later, a follow up magnetic resonance imaging. We evaluated retinal vascular sign phenotypes as predictors of (1) leukoaraiosis volume increase, and (2) a new score combining leukoaraiosis volume change and incident lacunar infarcts. Hypertension and diabetes mellitus were evaluated as confounders and effect modifiers. Results— Individuals with any retinopathy (3.34 cm 3 ; 95% confidence interval [CI], 0.74–5.96) or with arteriovenous nicking (2.61 cm 3 ; 95% CI, 0.80–4.42) each had greater progression of leukoaraiosis compared with those without these conditions. Any retinopathy (odds ratio [OR], 3.18; 95% CI, 1.71–5.89) or its components—microaneurysms (OR, 3.06; 95% CI, 1.33–7.07) and retinal hemorrhage (OR, 3.02; 95% CI, 1.27–7.20)—as well as arteriovenous nicking (OR, 1.93; 95%, CI 1.24–3.02) and focal arteriolar narrowing (OR, 1.76; 95% CI, 1.19–2.59), were associated with a higher quartile of a novel brain microvascular disease score combining leukoaraiosis progression with incident subclinical lacunes. Conclusions— A novel scoring method revealed associations of retinal signs with leukoaraiosis progression and brain microvascular disease, which have not been shown before.
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Maurer, Matthew J. , Ghesquières, Hervé , Jais, Jean‐Philippe, Haïoun, Corinne , Thompson, Carrie A. , Delarue, Richard, Micallef, Ivana N. , Peyrade, Frédéric, Macon, William R. , Molina, Thierry Jo , Ketterer, Nicolas , Syrbu, Sergei , Fitoussi, Olivier , Kurtin, Paul J. , Allmer, Cristine, Nicolas‐Virelizier, Emmanuelle , Link, Brian K. , Salles, Gilles , Tilly, Hervé , Cerhan, James R. , Jaïs, Jean‐Philippe , Witzig, Thomas E. , Slager, Susan L. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Link, Brian K , Salles, Gilles A , Syrbu, Sergei

Journal of Clinical Oncology | February 19, 2014 | Volume: 32 | Issue: 10 | Pages: 1066-1073

10.1200/jco.2013.51.5866 | PMID 24550425 Get It

Purpose Studies of diffuse large B-cell lymphoma (DLBCL) are typically evaluated by using a time-to-event approach with relapse, re-treatment, and death commonly used as the events. We evaluated the timing and type of events in newly diagnosed DLBCL and compared patient outcome with reference population data. Patients and Methods Patients with newly diagnosed DLBCL treated with immunochemotherapy were prospectively enrolled onto the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource (MER) and the North Central Cancer Treatment Group NCCTG-N0489 clinical trial from 2002 to 2009. Patient outcomes were evaluated at diagnosis and in the subsets of patients achieving event-free status at 12 months (EFS12) and 24 months (EFS24) from diagnosis. Overall survival was compared with age- and sex-matched population data. Results were replicated in an external validation cohort from the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Lymphome Non Hodgkinien 2003 (LNH2003) program and a registry based in Lyon, France. Results In all, 767 patients with newly diagnosed DLBCL who had a median age of 63 years were enrolled onto the MER and NCCTG studies. At a median follow-up of 60 months (range, 8 to 116 months), 299 patients had an event and 210 patients had died. Patients achieving EFS24 had an overall survival equivalent to that of the age- and sex-matched general population (standardized mortality ratio [SMR], 1.18; P = .25). This result was confirmed in 820 patients from the GELA study and registry in Lyon (SMR, 1.09; P = .71). Simulation studies showed that EFS24 has comparable power to continuous EFS when evaluating clinical trials in DLBCL. Conclusion Patients with DLBCL who achieve EFS24 have a subsequent overall survival equivalent to that of the age- and sex-matched general population. EFS24 will be useful in patient counseling and should be considered as an end point for future studies of newly diagnosed DLBCL.
Dramatic Response to Pazopanib in a Patient With Metastatic Malignant Granular Cell Tumor
Conley, Anthony P. , Koplin, Stephanie A., Caracciollo, Jamie T., Webber, Nicolas P., Attia, Steven , Reed, Damon R. , Conley, Anthony P

Journal of Clinical Oncology | February 19, 2014 | Volume: 32 | Issue: 32 | Pages: e107-e110

10.1200/jco.2012.47.1078 | PMID 24550417 Get It

Editor’s Perspective: The Isthmus of Uncertainty
Asirvatham, Samuel J. , Stevenson, William G. , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | February 18, 2014 | Volume: 7 | Issue: 1 | Pages: 175-177

10.1161/circep.114.001425 | PMID 24550408 Get It

Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis
Pandit, Anil , Aryal, Madan Raj , Pandit, Aashrayata Aryal, Hakim, Fayaz A., Mainali, Naba Raj , Lee, Howard R., Fortuin, F. David , Mookadam, Farouk , Aryal Pandit, Aashrayata, Hakim, Fayaz Ahmad, Sharma, Prashant , Giri, Smith , Sharma, Prashant Kumar , Mookadam, Farouk

Open Heart | February 18, 2014 | Volume: 1 | Issue: 1 | Pages: e000012

10.1136/openhrt-2013-000012 | PMID 25332779 Get It

Aim The benefit of preventive percutaneous coronary intervention (PCI) in ST elevation myocardial infarction (STEMI) has been shown in randomised trials. However, all the randomised trials are underpowered to detect benefit in cardiac death. We aim to systematically review evidence on the cardiac mortality benefit of preventive PCI in patients presenting with acute STEMI in randomised patient populations. Methods PubMed, Scopus, Cochrane and clinicaltrials.gov databases were searched for studies published until 30 September 2013. The studies were limited to randomised clinical trials. Independent observers abstracted the data on outcomes, characteristics and qualities of studies included. Fixed effect model was employed for meta-analysis. Heterogeneity of studies included was analysed using I2 statistics. Results In three randomised clinical trials published, involving 748 patients with acute STEMI and multivessel disease, 416 patients were randomised to preventive PCI and 332 to culprit-only PCI. Patients undergoing preventive PCI had significant lower risk of cardiovascular deaths (pooled OR 0.39, 95% CI 0.18 to 0.83, p=0.01, I2=0%), repeat revascularisation (pooled OR 0.28, 95% CI 0.18 to 0.44, p=0.00001, I2=0%) and non-fatal myocardial infarction (pooled OR 0.38, 95% CI 0.20 to 0.75, p=0.005, I2=0%) compared with culprit-only revascularisation. Conclusions In patients presenting with acute STEMI and significant multivessel coronary artery disease, based on our data, preventive PCI is associated with lower risk of cardiovascular mortality compared with primary PCI of only the culprit artery. This finding needs to be confirmed in larger adequately powered randomised clinical trials.
Vitamin D levels and left ventricular diastolic function
Pandit, Anil , Mookadam, Farouk , Boddu, Sailaja, Pandit, Aashrayata Aryal, Tandar, Anwar , Chaliki, Hari P. , Cha, Stephen, Lee, Howard R., Aryal Pandit, Aashrayata, Chaliki, Hari

Open Heart | February 18, 2014 | Volume: 1 | Issue: 1 | Pages: e000011

10.1136/openhrt-2013-000011 | PMID 25332778 Get It

Objective To determine the association between serum vitamin D level and left ventricular (LV) diastolic dysfunction. Background Vitamin D deficiency has been shown in observational and prospective studies to be associated with cardiovascular diseases including coronary artery disease, LV hypertrophy and systolic heart failure. Even though diastolic LV dysfunction is an early manifestation of cardiac disease, there is no study that examines whether a deficiency of vitamin D is associated with LV diastolic dysfunction. Method A retrospective observational review of 1011 patients (679 women) was conducted to examine if low 25-OH-vitamin D levels were associated with LV diastolic dysfunction. Results All the LV diastolic dysfunction parameters: left atrial volume index, E/e', e' velocity, LV mass index and deceleration time were not significantly different between patients with 25-OH vitamin D level ≤20 ng/mL vs 25-OH vitamin D level >20 ng/mL. Conclusions Despite growing medical literature suggesting vitamin D deficiency is associated with cardiovascular disease, in this present study there is no significant association of vitamin D levels and LV diastolic performance, including left atrial volume index.